Repplinger, Michael D.
Nagle, Scott K.
Harringa, John B.
Broman, Aimee T.
Lindholm, Christopher R.
François, Christopher J.
Grist, Thomas M.
Reeder, Scott B.
Schiebler, Mark L.
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (K08DK111234, K24DK102595)
National Center for Advancing Translational Sciences (UL1TR000427, KL2TR000428)
Article History
Received: 1 March 2018
Accepted: 25 April 2018
First Online: 10 May 2018
Compliance with ethical standards
: This study was approved by the University of Wisconsin Health Sciences Institutional Review Board and adhered to regulations as outlined in the Health Insurance Portability and Accountability Act.
: The University of Wisconsin - Madison Department of Radiology receives research support from GE Healthcare and Bracco Diagnostics. Scott B. Reeder, MD, PhD has the following financial disclosures: Co-founder of Calimetrix; shareholder, Cellectar Biosciences and Elucent Medical; consultant for Parexel International. The other authors declare that they have no conflicts of interest.